NO792085L - Fremgangsmaate ved fremstilling av terapeutisk virksomme l-cysteinderivater - Google Patents

Fremgangsmaate ved fremstilling av terapeutisk virksomme l-cysteinderivater

Info

Publication number
NO792085L
NO792085L NO792085A NO792085A NO792085L NO 792085 L NO792085 L NO 792085L NO 792085 A NO792085 A NO 792085A NO 792085 A NO792085 A NO 792085A NO 792085 L NO792085 L NO 792085L
Authority
NO
Norway
Prior art keywords
procedures
preparation
therapeutic activities
cystein
derivatives
Prior art date
Application number
NO792085A
Other languages
English (en)
Other versions
NO146325B (no
NO146325C (no
Inventor
Jean-Pierre Maffrand
Original Assignee
Parcor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parcor filed Critical Parcor
Publication of NO792085L publication Critical patent/NO792085L/no
Publication of NO146325B publication Critical patent/NO146325B/no
Publication of NO146325C publication Critical patent/NO146325C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO792085A 1978-06-22 1979-06-21 Analogifremgangsmaate ved fremstilling av terapeutisk virksomme l-cysteinderivater NO146325C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7818693A FR2434149A1 (fr) 1978-06-22 1978-06-22 Nouveaux derives de la l-cysteine

Publications (3)

Publication Number Publication Date
NO792085L true NO792085L (no) 1979-12-28
NO146325B NO146325B (no) 1982-06-01
NO146325C NO146325C (no) 1982-09-08

Family

ID=9209845

Family Applications (1)

Application Number Title Priority Date Filing Date
NO792085A NO146325C (no) 1978-06-22 1979-06-21 Analogifremgangsmaate ved fremstilling av terapeutisk virksomme l-cysteinderivater

Country Status (26)

Country Link
US (1) US4248890A (no)
EP (1) EP0006784B1 (no)
JP (1) JPS557276A (no)
AR (1) AR224366A1 (no)
AT (1) AT365567B (no)
AU (1) AU521501B2 (no)
BE (1) BE877080A (no)
CA (1) CA1119610A (no)
CH (1) CH643539A5 (no)
DE (1) DE2962886D1 (no)
DK (1) DK258179A (no)
ES (1) ES481271A1 (no)
FI (1) FI791974A7 (no)
FR (1) FR2434149A1 (no)
GB (1) GB2023598B (no)
GR (1) GR67277B (no)
IE (1) IE48351B1 (no)
IL (1) IL57488A (no)
IT (1) IT1124103B (no)
LU (1) LU81409A1 (no)
MX (1) MX5987E (no)
NO (1) NO146325C (no)
NZ (1) NZ190665A (no)
PH (1) PH14005A (no)
PT (1) PT69792A (no)
ZA (1) ZA792759B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765817B1 (en) 2008-12-03 2014-07-01 Arrowhead Center, Inc. Selective inhibitors of EG5 motors and methods of use
US8349899B1 (en) 2008-12-03 2013-01-08 Arrowhead Center, Inc. Selective inhibitors of EG5 motors and methods of use
CA2974210A1 (en) 2015-01-30 2016-08-04 Parion Sciences, Inc. Novel monothiol mucolytic agents
JOP20190095A1 (ar) 2016-10-27 2019-04-28 Janssen Pharmaceutica Nv مركبات ببتيد تيروسين-تيروسين الحلقية كمعدلات لمستقبلات الببتيد العصبي y

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3137722A (en) * 1961-06-09 1964-06-16 California Research Corp Beta-(omicron-carboxybenzylmercapto) propionitrile
NL144484B (nl) * 1967-07-26 1975-01-15 Merck & Co Inc Werkwijze ter bereiding van een geneesmiddel met anti-anflammatoire werking, alsmede werkwijze ter bereiding van de anti-inflammatoir werkzame aralkylmercaptoaminozuren.

Also Published As

Publication number Publication date
NZ190665A (en) 1981-12-15
PH14005A (en) 1980-11-28
IT7912638A0 (it) 1979-06-12
EP0006784A3 (en) 1980-04-16
AT365567B (de) 1982-01-25
JPS557276A (en) 1980-01-19
FR2434149A1 (fr) 1980-03-21
AU4787379A (en) 1980-01-03
AR224366A1 (es) 1981-11-30
NO146325B (no) 1982-06-01
IL57488A (en) 1983-02-23
EP0006784A2 (fr) 1980-01-09
IE791164L (en) 1979-12-22
CA1119610A (en) 1982-03-09
ZA792759B (en) 1980-08-27
PT69792A (fr) 1979-07-01
FR2434149B1 (no) 1981-01-16
ES481271A1 (es) 1980-01-01
GB2023598A (en) 1980-01-03
FI791974A7 (fi) 1981-01-01
GR67277B (no) 1981-06-26
BE877080A (fr) 1979-12-19
AU521501B2 (en) 1982-04-08
NO146325C (no) 1982-09-08
US4248890A (en) 1981-02-03
IL57488A0 (en) 1979-10-31
DE2962886D1 (en) 1982-07-08
CH643539A5 (fr) 1984-06-15
GB2023598B (en) 1982-07-21
IT1124103B (it) 1986-05-07
MX5987E (es) 1984-09-14
ATA438479A (de) 1981-06-15
EP0006784B1 (fr) 1982-05-19
DK258179A (da) 1979-12-23
IE48351B1 (en) 1984-12-26
LU81409A1 (fr) 1979-09-12

Similar Documents

Publication Publication Date Title
NO149962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO790358L (no) Fremgangsmaate for fremstilling av alkylendiaminderivater
NO151321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater
NO148148C (no) Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater
ES494635A0 (es) Procedimiento de preparacion de derivados de tiadiazol
NO792404L (no) Fremgangsmaate for fremstilling av imidazolderivater
NO151201C (no) Fremgangsmaate for fremstilling av terapeutisk virksomme antigenderivater
NO773682L (no) Fremgangsmaate ved fremstilling av furocumariner
NO782756L (no) Fremgangsmaate for fremstilling av terapeutisk aktive antrakinonderivater
NO794317L (no) Fremgangsmaate for fremstilling av pyrido-indolderivater
NO814055L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive thienopyridinonderivater
NO781168L (no) Fremgangsmaate ved fremstilling av diasepinderivater
NO150156C (no) Fremgangsmaate ved fremstilling av 5(6)-thio-benzimidazolderivater
NO150799C (no) Fremgangsmaate for fremstilling av lysergol-derivater
SE7803035L (sv) Forfarande for framstellning av tienopyridinderivat
NO784382L (no) Fremgangsmaate for fremstilling av tiazoldin-derivater
NO783705L (no) Fremgangsmaate ved fremstilling av quinazolinderivater
NO801982L (no) Fremgangsmaate ved fremstilling av svovelholdige isokinolinderivater
NO782411L (no) Fremgangsmaate ved fremstilling av thienopyridinderivater
NO148452C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-fenyl-1-propanol-derivater
NO780644L (no) Fremgangsmaate til fremstilling av terapeutisk virksomme 9-hydroksyetoksymetylguanin-derivater
NO780190L (no) Fremgangsmaate ved fremstilling av urea
NO792085L (no) Fremgangsmaate ved fremstilling av terapeutisk virksomme l-cysteinderivater
NO780389L (no) Fremgangsmaate for fremstilling av erytromycin-derivater
NO791220L (no) Fremgangsmaate ved fremstilling av 4-aza-17-substituert-5alfa-androstan-3-oner